Anixa Biosciences, Inc. Analysis
Analyst Ratings |
Average Target Price
|
9.50
|
Average Rating
|
4.50
|
# Strong Buys
|
1
|
# Buys
|
1
|
# Holds
|
0
|
# Sells
|
0
|
# Strong Sells
|
0
|
Quarterly Earnings History |
Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
2023-01-31
|
-0.16
|
0.00
|
0.16
|
100.00%
|
2022-10-31
|
-0.11
|
-0.12
|
-0.01
|
-9.09%
|
2022-07-31
|
-0.13
|
-0.09
|
0.04
|
30.77%
|
2022-04-30
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
2022-01-31
|
-0.13
|
-0.13
|
0.00
|
0.00%
|
2021-10-31
|
-0.09
|
-0.13
|
-0.04
|
-44.44%
|
2021-07-31
|
-0.08
|
-0.14
|
-0.06
|
-75.00%
|
2021-04-30
|
-0.10
|
-0.08
|
0.02
|
20.00%
|
Annual Earnings History |
Fiscal Year End |
EPS |
2022-10-31
|
-0.46
|
2021-10-31
|
-0.44
|
2020-10-31
|
-0.44
|
2019-10-31
|
-0.57
|
2018-10-31
|
-0.75
|
2017-10-31
|
-0.63
|
2016-10-31
|
-0.57
|
2015-10-31
|
-0.18
|
2014-10-31
|
-1.12
|
2013-10-31
|
-0.96
|
2012-10-31
|
-0.59
|
2011-10-31
|
-1.12
|
2010-10-31
|
-0.88
|
2009-10-31
|
-2.96
|
2008-10-31
|
-1.28
|
2007-10-31
|
-1.33
|
2006-10-31
|
-2.03
|
2005-10-31
|
-1.27
|
2004-10-31
|
-1.02
|
2003-10-31
|
-8.82
|